Obesity

Global CV mortality and the prevalence of important cardiometabolic risk factors increased through 2022, with high BP remaining the strongest contributor, according to the 2023 update to the Global Burden of Disease special report on CVD.

Caloric restriction and exercise improved domains of cognitive function in a small study of older patients with obesity and HF with preserved ejection fraction, according to a research letter published in Circulation: Heart Failure.

Presentations on the latest cardiometabolic research, panel discussions and updated practice recommendations are among this year’s highlights at the 21st World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.

A cardiology-driven clinic for outpatients with heart failure appears to be an effective setting for weight loss in patients with obesity and HF, according to a research letter published in JACC: Advances.

Five obesity advocacy groups are calling on the FDA to require drug trials to include people with obesity and to update labels for drugs that may affect people with obesity differently.

Ultraprocessed foods are associated with poor health outcomes, but helping patients reduce their intake can be difficult because of their prevalence, broad definition and affordability, according to experts.

Women with metabolic syndrome are more likely to have increased risk for atherosclerotic changes than women without metabolic syndrome, regardless of whether they also have obesity, according to study findings published in Menopause.

Healio and Cardiology Today have compiled a list of the most-read news in cardiology of November 2023.

PHILADELPHIA — The association between obesity and chronic kidney disease may be partially explained by inflammatory cytokines and high levels of leptin, according to data from a study presented at ASN Kidney Week.

Higher BMI increased the risk for obesity-related cancer among a cohort of European adults, irrespective of cardiometabolic disease status, according to study results.